Home » today » World » Study: Pfizer / BioNTech Third Vaccine Significantly Strengthens Protective Effect on Seniors – Health – News

Study: Pfizer / BioNTech Third Vaccine Significantly Strengthens Protective Effect on Seniors – Health – News

People who have received two doses of the vaccine have at least ten times more confirmed infections and nearly 20 times more cases of serious illness than people who have received three doses, according to Israeli researchers.

In Israel, all vaccinees now have the opportunity to receive the primary vaccine no earlier than five months after the second vaccination.

Despite the large vaccination coverage, the country is currently battling a third wave of coronavirus.

According to Israeli researchers, the most contagious delta strain of the virus, as well as a reduction in protection six months after the second dose of the vaccine, causes the level of protection against infection to drop to 50%.

According to the Secretary General of the German Society for Immunology, Karsten Vacl, told the DPA, the level of antibodies after the third dose was ten times higher than after the second dose.

However, the study now confirms that this “means a very, very polite protective effect”.

However, the possibility of side effects has not been evaluated in the study, Vacls pointed out.

To date, there are no reports from Israel that the third dose causes more side effects than the second.

Vacl also does not recommend a booster vaccine for young people, but for anyone over the age of 80 and those over the age of 60 with a history of the disease.

In Germany, people over the age of 80 and people with an immunodeficiency are already sometimes offered a third dose for people in need of care.

— .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.